The Human Plutonium Injection Experiments
Yüklə 0,81 Mb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- Table 2. The Eighteen Patients Injected With Plutonium Case number and Date Date Survival Age at
- Weight of Activity Total Dose to Ailments, tissue samples, injected of Pu-239
The Human Plutonium Injection Experiments 208
Los Alamos Science Number 23 1995 Table 2. The Eighteen Patients Injected With Plutonium Case number and Date Date Survival Age at Cause of description Injected* of death time death* death HP-12
April 10, 1945 Apr. 13, 1953 2,925 days 63 heart failure 55-yr-old man (8.0 yrs) CHI-1 April 26, 1945 Oct. 3, 1945 160 days
68 cancer of chin, lungs 68-yr-old man (5.2 months) CAL-1 May 14, 1945 Jan. 9, 1966 7,545 days 79 heart disease 58-yr-old man (20.7 yrs) HP-1 Oct. 16, 1945 Jan. 12, 1960 5,201 days 81 bronchopneumonia 67-yr-old man (14.2 yrs) HP-2 Oct. 23, 1945 Apr. 4, 1948 894 days
50 brain disease 48-yr-old man (2.4 yrs) HP-3 Nov. 27, 1945 Jan. 24, 1983 13,571 days 85 acute cardiac arrest 48-yr-old woman (37.2 yrs) HP-4 Nov. 27, 1945 Apr. 29, 1947 518 days
20 Cushing’s syndrome 18-yr-old woman (1.4 yrs) HP-5 Nov. 30, 1945 Apr. 29, 1946 150 days
57 bronchopneumonia 56-yr-old man (4.9 months) CHI-2 Dec. 27, 1945 Jan. 13, 1946 17 days
56 breast cancer 56-yr-old woman CHI-3
Dec. 27, 1945 June 1946 about 170 days not
probably young adult male (5.6 months) known
Hodgin’s Disease HP-6
Feb. 1, 1946 May 6, 1984 13,974 days 82 natural death 44-yr-old man (38.2 yrs) HP-7 Feb. 8, 1946 Oct. 27, 1946 261 days
60 pulmonary failure 59-yr-old woman (8.5 months) HP-11 Feb. 20, 1946 Feb. 26, 1946 6 days
69 bronchopneumonia 69-yr-old man HP-8
March 9, 1946 Nov. 22, 1975 10,850 days 71 unknown 41-yr-old woman (29.7 yrs) HP-9 April 3, 1946 July 2, 1947 455 days
65 bronchopneumonia 64-yr-old man (1.2 yrs) CAL-2 April 26, 1946 Jan. 6, 1947 255 days
5 bone cancer 4-yr, 10-month-old boy (8.4 months) HP-10 July 16, 1946 June 2, 1957 3,974 days 63 heart disease 52-yr-old man (10.9 yrs) CAL-3 July 18, 1947 June 30, 1991 16,050 days 80 respiratory failure, 36-yr-old man (44.0 yrs) pneumonia *The ages at injection and at death are based on the known dates of birth as determined by Pat Durbin; they differ in a few cases from the ages given by Langham, et. al., in LA-1151. Some of the dates of death are based on information found by Eileen Welsome. **The injection dose gives an upper limit for the patient’s body burden. For example, it is now estimated that after 27 years, about 82.4 per cent of the injected dose would still remain in the body.
The Human Plutonium Injection Experiments Number 23 1995 Los Alamos Science 209
m
(nCi) dose (rem) † ratio ‡ 4.7
290 230
80 auto accident victim at Oak Ridge Hospital; bone sample taken in surgery, teeth obtained later 6.5
400 19 120 cancer of chin, metastasis to lungs; near death when injected; autospy samples taken 0.75 (239) 46 (239)
6400 858
gastric neoplasm; misdiagnosed with stomach 0.20 (238) 3,500 (238) cancer; tumor and other tissue taken in surgery 4.6 280
380 74 duodenal ulcer, severe gastrointestinal hemorrhage 5.1
310 80 92 hemophilia and heart disease 4.9
300 880
66 rash, hepatitis, and hypoproteinemia 4.9 300
46 90 Cushing’s syndrome, a metabolic disorder 5.1 310
14 95 Lou Gehrig’s disease; autopsy samples taken 94.9
5,900 29 1730 breast cancer that had metastasized; autospy samples taken 94.9 5,900
300 1790
Hodgkin’s disease 5.3
330 990
72 Addison’s disease, a hormonal deficiency disease 6.3 390
30 117
rheumatic heart disease 6.5
400 0.6
100 chronic malnutrition, alcoholism, cirrhosis of liver; moribund at injection; autospy samples taken 6.5
400 1000
94 scleroderma, a chronic skin disease, and duodenal ulcer 6.3
390 52 116 generalized dermititis and weakness; autospy samples taken 2.7 (plus radio- 169 13 52 osteogenic sarcoma, a rare form of bone cancer; cerium & yttrium) bone samples taken 6.1
380 410
104 acute congestive heart failure 0.006 (238) 95 155 10 purportedly bone cancer in left knee; leg amputation removed half the plutonium; bone samples taken; injection was intramuscular †The total effective dose was calculated using biokinetic models recommended by the International Commission on Radiological Protection, ICRP Publication 30, and all the values represent the dose received by each individual over the period from the time of injection to the time of death. ‡The dose to background ratio was calculated by taking the ratio of the patient’s total effective dose to the estimated dose for an average U.S. citizen over the period from the time of injection to the time of death (where the average annual U.S. effective dose equivalent was taken to be 0.360 rem). Yüklə 0,81 Mb. Dostları ilə paylaş:
|